封面
市场调查报告书
商品编码
1617700

医疗保健契约製造市场:按製造类型、最终用户划分 - 2025-2030 年全球预测

Healthcare Contract Manufacturing Market by Manufacturing Type (Accessories Manufacturing, Assembly Manufacturing, Component Manufacturing), End-Users (Medical Device Companies, Pharmaceutical & Biopharmaceutical Companies) - Global Forecast 2025-2030

出版日期: | 出版商: 360iResearch | 英文 181 Pages | 商品交期: 最快1-2个工作天内

价格

本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年,医疗保健契约製造市场价值为1860亿美元,预计到2024年将达到2016.8亿美元,复合年增长率为8.49%,到2030年将达到3292.2亿美元。

医疗保健契约製造是指将生产过程外包给专业的第三方公司,让製药和医疗设备公司专注于研发等核心能力。这项需求是由成本效率、扩充性、法规遵循和专业知识的获取所驱动的。应用领域广泛,包括製药、生技产品、医疗设备及诊断。最终用途包括医院、实验室、商业企业等。市场成长是由不断增加的研发投资、对学名药和生技药品的强劲需求以及医疗技术的进步所推动的。人口迅速老化和慢性病盛行率上升进一步增加了这项需求。由于医疗保健计划的扩大和医疗支出的增加,新兴市场提供了巨大的商机。公司可以受益于利用当地製造业的优势并与区域企业建立策略伙伴关係。然而,他们面临严格的法规环境、复杂的物流、品质保证挑战和智慧财产权问题等挑战。为了应对这些挑战,公司必须投资强大的品管流程并确保符合国际标准。创新路径包括采用 3D 列印和物联网等先进製造技术、利用区块链简化供应链以及利用资料分析来获得预测见解。环保生产技术等永续实践也有望在竞争格局中脱颖而出。市场既竞争又协作,要求製造商保持灵活性,以适应不断变化的客户需求和监管变化。市场的动态本质要求不断创新,不仅在产品供应方面,而且在服务供应方面,确保对市场波动的快速反应。对新兴市场和技术进步的策略关注可以帮助企业实现永续成长。最终,了解当地消费行为和监管细微差别对于抓住医疗保健契约製造领域的全球商机至关重要。

主要市场统计
基准年[2023] 1860亿美元
预计年份 [2024] 2016.8亿美元
预测年份 [2030] 3292.2亿美元
复合年增长率(%) 8.49%

市场动态:揭示快速发展的医疗保健契约製造市场的关键市场洞察

医疗保健契约製造市场正在因供需的动态相互作用而发生转变。透过了解这些不断变化的市场动态,公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险,同时消费行为及其对製造成本的影响以及对采购趋势的影响。

  • 市场驱动因素
    • 製药公司外包端到端服务的趋势不断成长
    • 契约製造增加对先进製造技术的投资
    • 对一站式开发和製造合约组织的需求不断增加
  • 市场限制因素
    • 外包中的合规问题以及严格的法规和法律体制
  • 市场机会
    • 对核子医学和专科药物的日益关注
    • 对生物疗法的需求不断增长
  • 市场挑战
    • 影响医疗保健契约製造组织盈利的运转率问题

波特五力:驾驭医疗保健契约製造市场的策略工具

波特的五力框架是了解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势,解决弱点并避免潜在的挑战,从而确保更强大的市场地位。

PESTLE分析:了解医疗保健契约製造市场的外部影响

外部宏观环境因素在塑造医疗保健契约製造市场的绩效动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素,公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化,并帮助他们做出积极主动的决策。

市场占有率分析 了解医疗保健契约製造市场的竞争状况

对医疗保健契约製造市场的详细市场占有率分析可以对供应商绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势,为供应商提供了製定策略决策所需的洞察力,使他们能够在日益激烈的竞争中占有一席之地。

FPNV 定位矩阵供应商在医疗保健契约製造市场的绩效评估

FPNV定位矩阵是评估医疗保健契约製造市场供应商的重要工具。此矩阵允许业务组织根据供应商的商务策略和产品满意度评估供应商,从而做出符合其目标的明智决策。这四个象限使您能够清晰、准确地划分供应商,并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析与建议,规划医疗保健契约製造市场的成功之路

对于旨在加强其在全球市场的影响力的公司来说,医疗保健契约製造市场的策略分析至关重要。透过审查关键资源、能力和绩效指标,公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战,利用新的商机,并取得长期成功。

本报告对市场进行了全面分析,涵盖关键重点领域:

1. 市场渗透率:对当前市场环境的详细审查、主要企业的广泛资料、对其在市场中的影响力和整体影响力的评估。

2. 市场开拓:辨识新兴市场的成长机会,评估现有领域的扩张潜力,并提供未来成长的策略蓝图。

3. 市场多元化:分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报:彻底分析竞争格局,检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新:重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题,帮助相关人员做出明智的决策:

1.目前的市场规模和未来的成长预测是多少?

2. 哪些产品、区隔市场和地区提供最佳投资机会?

3.塑造市场的主要技术趋势和监管影响是什么?

4.主要厂商的市场占有率和竞争地位如何?

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么?

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 製药公司端到端外包趋势增加
      • 契约製造製造商增加对先进製造技术的投资
      • 对一站式合约开发和製造组织的需求不断增加
    • 抑制因素
      • 外包中的合规问题以及严格的法规和法律体制
    • 机会
      • 对核子医学和专科药物的关注增加
      • 生物治疗的需求不断增加
    • 任务
      • 影响医疗保健契约製造组织盈利的产能利用率问题
  • 市场区隔分析
    • 製造类型:製造流程的进步透过契约製造为不同的客户需求提供客製化的解决方案。
    • 最终用户:契约製造开始开发高度复杂的生物产品。
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章按製造类型分類的医疗保健契约製造市场

  • 配件製造
  • 组装製造
  • 零件製造
  • 装置製造
  • 药品製造
    • 先进的药物传输配方
    • 原料药/原料药
    • 最终剂量配方
    • 包裹

第七章 医疗保健契约製造市场:依最终用户分类

  • 医疗设备公司
  • 製药和生物製药公司

第八章美洲医疗保健契约製造市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第九章亚太地区医疗保健契约製造市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十章 欧洲、中东和非洲的医疗保健契约製造市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十一章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵,2023
  • 竞争情境分析
    • Biomeric 宣布与 Precision Concepts Medical 合併
    • PCI Pharma 宣布斥资 5,000 万美元扩建伊利诺州注射药品厂
    • Medisurge 与 Signal Medical 宣布策略联盟
  • 战略分析和建议

公司名单

  • AbbVie, Inc.
  • Aenova Group
  • Almac Group
  • Baxter International, Inc.
  • Biozoc Inc.
  • Boehringer Ingelheim International GmbH
  • Cambrex Corporation
  • Curia Global, Inc.
  • Evonik Industries AG
  • Famar Group
  • Jubilant Biosys Limited
  • Lonza Group Ltd.
  • Mitsubishi Tanabe Pharma Corporation
  • Pfizer Inc.
  • Pidolma Healthcare Private Limited
  • Recipharm AB
  • Thermo Fisher Scientific Inc.
Product Code: MRR-8C74ADFC054D

The Healthcare Contract Manufacturing Market was valued at USD 186.00 billion in 2023, expected to reach USD 201.68 billion in 2024, and is projected to grow at a CAGR of 8.49%, to USD 329.22 billion by 2030.

Healthcare contract manufacturing involves outsourcing production processes to specialized third-party firms, enabling pharmaceutical and medical device companies to focus on core competencies like research and development. The necessity stems from cost efficiency, scalability, regulatory compliance, and access to specialized expertise. Application areas span pharmaceuticals, biotechnology products, medical devices, and diagnostics. End-use scopes include hospitals, research labs, and commercial enterprises. Market growth is propelled by increased R&D investments, robust demand for generics and biologics, and advancements in medical technology. The burgeoning aging population and rising prevalence of chronic diseases further amplify this demand. Developing markets offer ripe opportunities due to expansive healthcare initiatives and increasing healthcare spending. Companies can capitalize by leveraging local manufacturing benefits and forming strategic partnerships with regional firms. Nonetheless, the market faces hurdles such as stringent regulatory environments, complex logistics, quality assurance challenges, and intellectual property issues. To navigate these, firms must invest in robust quality control processes and ensure compliance with international standards. Innovation avenues entail embracing advanced manufacturing technologies like 3D printing and IoT, streamlining supply chains through blockchain, and utilizing data analytics for predictive insights. Sustainable practices, such as eco-friendly production techniques, are also promising for differentiation in a competitive landscape. The market is highly competitive yet collaborative, requiring manufacturers to maintain flexibility to adapt to evolving client demands and regulatory shifts. The market's dynamic nature calls for continuous innovation, not just in product offerings but also in service delivery, ensuring rapid response to market fluctuations. With a strategic focus on emerging markets and technological advancements, companies can achieve sustainable growth. Ultimately, understanding local consumer behavior and regulatory nuances will be crucial for seizing global opportunities in healthcare contract manufacturing.

KEY MARKET STATISTICS
Base Year [2023] USD 186.00 billion
Estimated Year [2024] USD 201.68 billion
Forecast Year [2030] USD 329.22 billion
CAGR (%) 8.49%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Healthcare Contract Manufacturing Market

The Healthcare Contract Manufacturing Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Growing trend of outsourcing end-to-end services by pharmaceutical companies
    • Rising investments in advanced manufacturing technologies by contract manufacturers
    • Increasing demand for one-stop-shop contract development & manufacturing organization
  • Market Restraints
    • Compliance issues in outsourcing coupled with stringent regulatory and legal frameworks
  • Market Opportunities
    • Growing focus on nuclear medicine and specialty drugs
    • Increasing need for biological therapies
  • Market Challenges
    • Capacity utilization issues affecting the profitability of healthcare contract manufacturing organization

Porter's Five Forces: A Strategic Tool for Navigating the Healthcare Contract Manufacturing Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Healthcare Contract Manufacturing Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Healthcare Contract Manufacturing Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Healthcare Contract Manufacturing Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Healthcare Contract Manufacturing Market

A detailed market share analysis in the Healthcare Contract Manufacturing Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Healthcare Contract Manufacturing Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Healthcare Contract Manufacturing Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Healthcare Contract Manufacturing Market

A strategic analysis of the Healthcare Contract Manufacturing Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Healthcare Contract Manufacturing Market, highlighting leading vendors and their innovative profiles. These include AbbVie, Inc., Aenova Group, Almac Group, Baxter International, Inc., Biozoc Inc., Boehringer Ingelheim International GmbH, Cambrex Corporation, Curia Global, Inc., Evonik Industries AG, Famar Group, Jubilant Biosys Limited, Lonza Group Ltd., Mitsubishi Tanabe Pharma Corporation, Pfizer Inc., Pidolma Healthcare Private Limited, Recipharm AB, and Thermo Fisher Scientific Inc..

Market Segmentation & Coverage

This research report categorizes the Healthcare Contract Manufacturing Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Manufacturing Type, market is studied across Accessories Manufacturing, Assembly Manufacturing, Component Manufacturing, Device Manufacturing, and Pharmaceutical Manufacturing. The Pharmaceutical Manufacturing is further studied across Advanced Drug Delivery Formulations, API/Bulk Drugs, Finished Dose Formulations, and Packaging.
  • Based on End-Users, market is studied across Medical Device Companies and Pharmaceutical & Biopharmaceutical Companies.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing trend of outsourcing end-to-end services by pharmaceutical companies
      • 5.1.1.2. Rising investments in advanced manufacturing technologies by contract manufacturers
      • 5.1.1.3. Increasing demand for one-stop-shop contract development & manufacturing organization
    • 5.1.2. Restraints
      • 5.1.2.1. Compliance issues in outsourcing coupled with stringent regulatory and legal frameworks
    • 5.1.3. Opportunities
      • 5.1.3.1. Growing focus on nuclear medicine and specialty drugs
      • 5.1.3.2. Increasing need for biological therapies
    • 5.1.4. Challenges
      • 5.1.4.1. Capacity utilization issues affecting the profitability of healthcare contract manufacturing organization
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Manufacturing Type: Advancements in the manufacturing processes offer customized solutions for diverse client requirements through contract manufacturing
    • 5.2.2. End-User: Contract manufacturers expanded penetration to develop highly complex biological products
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Healthcare Contract Manufacturing Market, by Manufacturing Type

  • 6.1. Introduction
  • 6.2. Accessories Manufacturing
  • 6.3. Assembly Manufacturing
  • 6.4. Component Manufacturing
  • 6.5. Device Manufacturing
  • 6.6. Pharmaceutical Manufacturing
    • 6.6.1. Advanced Drug Delivery Formulations
    • 6.6.2. API/Bulk Drugs
    • 6.6.3. Finished Dose Formulations
    • 6.6.4. Packaging

7. Healthcare Contract Manufacturing Market, by End-Users

  • 7.1. Introduction
  • 7.2. Medical Device Companies
  • 7.3. Pharmaceutical & Biopharmaceutical Companies

8. Americas Healthcare Contract Manufacturing Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Healthcare Contract Manufacturing Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Healthcare Contract Manufacturing Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. FPNV Positioning Matrix, 2023
  • 11.3. Competitive Scenario Analysis
    • 11.3.1. Biomerics Announces Merger with Precision Concepts Medical
    • 11.3.2. PCI Pharma Unveils Plans for USD 50 Millions Expansion At Illinois Injectables Site
    • 11.3.3. Medisurge and Signal Medical Announce Strategic Partnership
  • 11.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. AbbVie, Inc.
  • 2. Aenova Group
  • 3. Almac Group
  • 4. Baxter International, Inc.
  • 5. Biozoc Inc.
  • 6. Boehringer Ingelheim International GmbH
  • 7. Cambrex Corporation
  • 8. Curia Global, Inc.
  • 9. Evonik Industries AG
  • 10. Famar Group
  • 11. Jubilant Biosys Limited
  • 12. Lonza Group Ltd.
  • 13. Mitsubishi Tanabe Pharma Corporation
  • 14. Pfizer Inc.
  • 15. Pidolma Healthcare Private Limited
  • 16. Recipharm AB
  • 17. Thermo Fisher Scientific Inc.

LIST OF FIGURES

  • FIGURE 1. HEALTHCARE CONTRACT MANUFACTURING MARKET RESEARCH PROCESS
  • FIGURE 2. HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. AMERICAS HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 11. AMERICAS HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. UNITED STATES HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 13. UNITED STATES HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. ASIA-PACIFIC HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. HEALTHCARE CONTRACT MANUFACTURING MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 19. HEALTHCARE CONTRACT MANUFACTURING MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. HEALTHCARE CONTRACT MANUFACTURING MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. HEALTHCARE CONTRACT MANUFACTURING MARKET DYNAMICS
  • TABLE 7. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY ACCESSORIES MANUFACTURING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY ASSEMBLY MANUFACTURING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY COMPONENT MANUFACTURING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY DEVICE MANUFACTURING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY ADVANCED DRUG DELIVERY FORMULATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY API/BULK DRUGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY FINISHED DOSE FORMULATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PACKAGING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MEDICAL DEVICE COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. AMERICAS HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING TYPE, 2018-2030 (USD MILLION)
  • TABLE 22. AMERICAS HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2018-2030 (USD MILLION)
  • TABLE 23. AMERICAS HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 24. AMERICAS HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 25. ARGENTINA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING TYPE, 2018-2030 (USD MILLION)
  • TABLE 26. ARGENTINA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2018-2030 (USD MILLION)
  • TABLE 27. ARGENTINA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 28. BRAZIL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING TYPE, 2018-2030 (USD MILLION)
  • TABLE 29. BRAZIL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2018-2030 (USD MILLION)
  • TABLE 30. BRAZIL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 31. CANADA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING TYPE, 2018-2030 (USD MILLION)
  • TABLE 32. CANADA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2018-2030 (USD MILLION)
  • TABLE 33. CANADA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 34. MEXICO HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING TYPE, 2018-2030 (USD MILLION)
  • TABLE 35. MEXICO HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2018-2030 (USD MILLION)
  • TABLE 36. MEXICO HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 37. UNITED STATES HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING TYPE, 2018-2030 (USD MILLION)
  • TABLE 38. UNITED STATES HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2018-2030 (USD MILLION)
  • TABLE 39. UNITED STATES HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 40. UNITED STATES HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 41. ASIA-PACIFIC HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING TYPE, 2018-2030 (USD MILLION)
  • TABLE 42. ASIA-PACIFIC HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2018-2030 (USD MILLION)
  • TABLE 43. ASIA-PACIFIC HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 44. ASIA-PACIFIC HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 45. AUSTRALIA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING TYPE, 2018-2030 (USD MILLION)
  • TABLE 46. AUSTRALIA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2018-2030 (USD MILLION)
  • TABLE 47. AUSTRALIA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 48. CHINA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING TYPE, 2018-2030 (USD MILLION)
  • TABLE 49. CHINA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2018-2030 (USD MILLION)
  • TABLE 50. CHINA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 51. INDIA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING TYPE, 2018-2030 (USD MILLION)
  • TABLE 52. INDIA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2018-2030 (USD MILLION)
  • TABLE 53. INDIA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 54. INDONESIA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING TYPE, 2018-2030 (USD MILLION)
  • TABLE 55. INDONESIA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2018-2030 (USD MILLION)
  • TABLE 56. INDONESIA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 57. JAPAN HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING TYPE, 2018-2030 (USD MILLION)
  • TABLE 58. JAPAN HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2018-2030 (USD MILLION)
  • TABLE 59. JAPAN HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 60. MALAYSIA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING TYPE, 2018-2030 (USD MILLION)
  • TABLE 61. MALAYSIA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2018-2030 (USD MILLION)
  • TABLE 62. MALAYSIA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 63. PHILIPPINES HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING TYPE, 2018-2030 (USD MILLION)
  • TABLE 64. PHILIPPINES HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2018-2030 (USD MILLION)
  • TABLE 65. PHILIPPINES HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 66. SINGAPORE HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING TYPE, 2018-2030 (USD MILLION)
  • TABLE 67. SINGAPORE HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2018-2030 (USD MILLION)
  • TABLE 68. SINGAPORE HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 69. SOUTH KOREA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING TYPE, 2018-2030 (USD MILLION)
  • TABLE 70. SOUTH KOREA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2018-2030 (USD MILLION)
  • TABLE 71. SOUTH KOREA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 72. TAIWAN HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING TYPE, 2018-2030 (USD MILLION)
  • TABLE 73. TAIWAN HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2018-2030 (USD MILLION)
  • TABLE 74. TAIWAN HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 75. THAILAND HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING TYPE, 2018-2030 (USD MILLION)
  • TABLE 76. THAILAND HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2018-2030 (USD MILLION)
  • TABLE 77. THAILAND HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 78. VIETNAM HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING TYPE, 2018-2030 (USD MILLION)
  • TABLE 79. VIETNAM HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2018-2030 (USD MILLION)
  • TABLE 80. VIETNAM HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 81. EUROPE, MIDDLE EAST & AFRICA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING TYPE, 2018-2030 (USD MILLION)
  • TABLE 82. EUROPE, MIDDLE EAST & AFRICA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2018-2030 (USD MILLION)
  • TABLE 83. EUROPE, MIDDLE EAST & AFRICA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 84. EUROPE, MIDDLE EAST & AFRICA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 85. DENMARK HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING TYPE, 2018-2030 (USD MILLION)
  • TABLE 86. DENMARK HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2018-2030 (USD MILLION)
  • TABLE 87. DENMARK HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 88. EGYPT HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING TYPE, 2018-2030 (USD MILLION)
  • TABLE 89. EGYPT HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2018-2030 (USD MILLION)
  • TABLE 90. EGYPT HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 91. FINLAND HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING TYPE, 2018-2030 (USD MILLION)
  • TABLE 92. FINLAND HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2018-2030 (USD MILLION)
  • TABLE 93. FINLAND HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 94. FRANCE HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING TYPE, 2018-2030 (USD MILLION)
  • TABLE 95. FRANCE HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2018-2030 (USD MILLION)
  • TABLE 96. FRANCE HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 97. GERMANY HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING TYPE, 2018-2030 (USD MILLION)
  • TABLE 98. GERMANY HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2018-2030 (USD MILLION)
  • TABLE 99. GERMANY HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 100. ISRAEL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING TYPE, 2018-2030 (USD MILLION)
  • TABLE 101. ISRAEL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2018-2030 (USD MILLION)
  • TABLE 102. ISRAEL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 103. ITALY HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING TYPE, 2018-2030 (USD MILLION)
  • TABLE 104. ITALY HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2018-2030 (USD MILLION)
  • TABLE 105. ITALY HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 106. NETHERLANDS HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING TYPE, 2018-2030 (USD MILLION)
  • TABLE 107. NETHERLANDS HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2018-2030 (USD MILLION)
  • TABLE 108. NETHERLANDS HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 109. NIGERIA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING TYPE, 2018-2030 (USD MILLION)
  • TABLE 110. NIGERIA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2018-2030 (USD MILLION)
  • TABLE 111. NIGERIA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 112. NORWAY HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING TYPE, 2018-2030 (USD MILLION)
  • TABLE 113. NORWAY HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2018-2030 (USD MILLION)
  • TABLE 114. NORWAY HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 115. POLAND HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING TYPE, 2018-2030 (USD MILLION)
  • TABLE 116. POLAND HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2018-2030 (USD MILLION)
  • TABLE 117. POLAND HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 118. QATAR HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING TYPE, 2018-2030 (USD MILLION)
  • TABLE 119. QATAR HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2018-2030 (USD MILLION)
  • TABLE 120. QATAR HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 121. RUSSIA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING TYPE, 2018-2030 (USD MILLION)
  • TABLE 122. RUSSIA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2018-2030 (USD MILLION)
  • TABLE 123. RUSSIA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 124. SAUDI ARABIA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING TYPE, 2018-2030 (USD MILLION)
  • TABLE 125. SAUDI ARABIA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2018-2030 (USD MILLION)
  • TABLE 126. SAUDI ARABIA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 127. SOUTH AFRICA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING TYPE, 2018-2030 (USD MILLION)
  • TABLE 128. SOUTH AFRICA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2018-2030 (USD MILLION)
  • TABLE 129. SOUTH AFRICA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 130. SPAIN HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING TYPE, 2018-2030 (USD MILLION)
  • TABLE 131. SPAIN HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2018-2030 (USD MILLION)
  • TABLE 132. SPAIN HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 133. SWEDEN HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING TYPE, 2018-2030 (USD MILLION)
  • TABLE 134. SWEDEN HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2018-2030 (USD MILLION)
  • TABLE 135. SWEDEN HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 136. SWITZERLAND HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING TYPE, 2018-2030 (USD MILLION)
  • TABLE 137. SWITZERLAND HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2018-2030 (USD MILLION)
  • TABLE 138. SWITZERLAND HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 139. TURKEY HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING TYPE, 2018-2030 (USD MILLION)
  • TABLE 140. TURKEY HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2018-2030 (USD MILLION)
  • TABLE 141. TURKEY HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 142. UNITED ARAB EMIRATES HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING TYPE, 2018-2030 (USD MILLION)
  • TABLE 143. UNITED ARAB EMIRATES HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2018-2030 (USD MILLION)
  • TABLE 144. UNITED ARAB EMIRATES HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 145. UNITED KINGDOM HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING TYPE, 2018-2030 (USD MILLION)
  • TABLE 146. UNITED KINGDOM HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2018-2030 (USD MILLION)
  • TABLE 147. UNITED KINGDOM HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 148. HEALTHCARE CONTRACT MANUFACTURING MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 149. HEALTHCARE CONTRACT MANUFACTURING MARKET, FPNV POSITIONING MATRIX, 2023